DOI QR코드

DOI QR Code

Measurement of Intra-Fraction Displacement of the Mediastinal Metastatic Lymph Nodes Using Four-Dimensional CT in Non-Small Cell Lung Cancer

  • Wang, Suzhen (Department of Radiation Oncology, Shandong Cancer Hospital & Institute) ;
  • Li, Jianbin (Department of Radiation Oncology, Shandong Cancer Hospital & Institute) ;
  • Zhang, Yingjie (Department of Radiation Oncology, Shandong Cancer Hospital & Institute) ;
  • Wang, Wei (Department of Radiation Oncology, Shandong Cancer Hospital & Institute) ;
  • Li, Fengxiang (Department of Radiation Oncology, Shandong Cancer Hospital & Institute) ;
  • Fan, Tingyong (Department of Radiation Oncology, Shandong Cancer Hospital & Institute) ;
  • Xu, Min (Department of Radiation Oncology, Shandong Cancer Hospital & Institute) ;
  • Shao, Qian (Department of Radiation Oncology, Shandong Cancer Hospital & Institute)
  • 발행 : 2012.08.01

초록

Objective: To measure the intra-fraction displacements of the mediastinal metastatic lymph nodes by using four-dimensional CT (4D-CT) in non-small cell lung cancer (NSCLC). Materials and Methods: Twenty-four patients with NSCLC, who were to be treated by using three dimensional conformal radiation therapy (3D-CRT), underwent a 4D-CT simulation during free breathing. The mediastinal metastatic lymph nodes were delineated on the CT images of 10 phases of the breath cycle. The lymph nodes were grouped as the upper, middle and lower mediastinal groups depending on the mediastinal regions. The displacements of the center of the lymph node in the left-right (LR), anterior-posterior (AP), and superior-inferior (SI) directions were measured. Results: The mean displacements of the center of the mediastinal lymph node in the LR, AP, and SI directions were 2.24 mm, 1.87 mm, and 3.28 mm, respectively. There were statistically significant differences between the displacements in the SI and LR, and the SI and AP directions (p < 0.05). For the middle and lower mediastinal lymph nodes, the displacement difference between the AP and SI was statistically significant (p = 0.005; p = 0.015), while there was no significant difference between the LR and AP directions (p < 0.05). Conclusion: The metastatic mediastinal lymph node movements are different in the LR, AP, and SI directions in patients with NSCLC, particularly for the middle and lower mediastinal lymph nodes. The spatial non-uniform margins should be considered for the metastatic mediastinal lymph nodes in involved-field radiotherapy.

키워드

참고문헌

  1. Fidler MJ, Kim AW, Zusag T, Bonomi P. Treatment of locally advanced non-small cell lung cancer. Clin Adv Hematol Oncol 2009;7:455-464;479-480
  2. Wagner TD, Yang GY. The role of chemotherapy and radiation in the treatment of locally advanced non-small cell lung cancer (NSCLC). Curr Drug Targets 2010;11:67-73 https://doi.org/10.2174/138945010790030956
  3. Emami B, Mirkovic N, Scott C, Byhardt R, Graham MV, James Andras E, et al. The impact of regional nodal radiotherapy (dose/volume) on regional progression and survival in unresectable non-small cell lung cancer: an analysis of RTOG data. Lung Cancer 2003;41:207-214 https://doi.org/10.1016/S0169-5002(03)00228-9
  4. Liengswangwong V, Bonner JA. Point: the potential importance of elective nodal irradiation in the treatment of non-small cell lung cancer. Semin Radiat Oncol 2000;10:308- 314 https://doi.org/10.1053/srao.2000.9279
  5. Fernandes AT, Shen J, Finlay J, Mitra N, Evans T, Stevenson J, et al. Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): a comparative analysis of toxicities and clinical outcomes. Radiother Oncol 2010;95:178-184 https://doi.org/10.1016/j.radonc.2010.02.007
  6. Rengan R, Rosenzweig KE, Venkatraman E, Koutcher LA, Fox JL, Nayak R, et al. Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2004;60:741-747 https://doi.org/10.1016/j.ijrobp.2004.04.013
  7. Yuan S, Sun X, Li M, Yu J, Ren R, Yu Y, et al. A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer. Am J Clin Oncol 2007;30:239-244 https://doi.org/10.1097/01.coc.0000256691.27796.24
  8. Rosenzweig KE, Sura S, Jackson A, Yorke E. Involved-field radiation therapy for inoperable non small-cell lung cancer. J Clin Oncol 2007;25:5557-5561 https://doi.org/10.1200/JCO.2007.13.2191
  9. Nakayama H, Satoh H, Kurishima K, Ishikawa H, Tokuuye K. High-dose conformal radiotherapy for patients with stage III non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys 2010;78:645-650 https://doi.org/10.1016/j.ijrobp.2009.08.037
  10. Ekberg L, Holmberg O, Wittgren L, Bjelkengren G, Landberg T. What margins should be added to the clinical target volume in radiotherapy treatment planning for lung cancer? Radiother Oncol 1998;48:71-77 https://doi.org/10.1016/S0167-8140(98)00046-2
  11. Saunders MI, Dische S, Barrett A, Parmar MK, Harvey A, Gibson D. Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and nonsmall- cell lung cancer: an interim report. CHART Steering Committee. Br J Cancer 1996;73:1455-1462 https://doi.org/10.1038/bjc.1996.276
  12. Shih HA, Jiang SB, Aljarrah KM, Doppke KP, Choi NC. Internal target volume determined with expansion margins beyond composite gross tumor volume in three-dimensional conformal radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 2004;60:613-622
  13. Low D. 4D imaging and 4D radiation therapy: a New Era of therapy design and delivery. Front Radiat Ther Oncol 2011;43:99-117
  14. Jenkins P, Salmon C, Mannion C. Analysis of the movement of calcified lymph nodes during breathing. Int J Radiat Oncol Biol Phys 2005;61:329-334 https://doi.org/10.1016/j.ijrobp.2004.05.063
  15. van Sornsen de Koste JR, Lagerwaard FJ, Nijssen-Visser MR, Schuchhard-Schipper R, Joosten H, Senan S. What margins are necessary for incorporating mediastinal nodal mobility into involved-field radiotherapy for lung cancer? Int J Radiat Oncol Biol Phys 2002;53:1211-1215 https://doi.org/10.1016/S0360-3016(02)02853-5
  16. Sher DJ, Wolfgang JA, Niemierko A, Choi NC. Quantification of mediastinal and hilar lymph node movement using fourdimensional computed tomography scan: implications for radiation treatment planning. Int J Radiat Oncol Biol Phys 2007;69:1402-1408 https://doi.org/10.1016/j.ijrobp.2007.05.022
  17. Keall P. 4-dimensional computed tomography imaging and treatment planning. Semin Radiat Oncol 2004;14:81-90 https://doi.org/10.1053/j.semradonc.2003.10.006
  18. Low DA, Nystrom M, Kalinin E, Parikh P, Dempsey JF, Bradley JD, et al. A method for the reconstruction of four-dimensional synchronized CT scans acquired during free breathing. Med Phys 2003;30:1254-1263 https://doi.org/10.1118/1.1576230
  19. Lu W, Parikh PJ, El Naqa IM, Nystrom MM, Hubenschmidt JP, Wahab SH, et al. Quantitation of the reconstruction quality of a four-dimensional computed tomography process for lung cancer patients. Med Phys 2005;32:890-901 https://doi.org/10.1118/1.1870152
  20. Rietzel E, Pan T, Chen GT. Four-dimensional computed tomography: image formation and clinical protocol. Med Phys 2005;32:874-889 https://doi.org/10.1118/1.1869852
  21. Keall PJ, Starkschall G, Shukla H, Forster KM, Ortiz V, Stevens CW, et al. Acquiring 4D thoracic CT scans using a multislice helical method. Phys Med Biol 2004;49:2053-2067 https://doi.org/10.1088/0031-9155/49/10/015
  22. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997;111:1718-1723 https://doi.org/10.1378/chest.111.6.1718
  23. Chapet O, Kong FM, Quint LE, Chang AC, Ten Haken RK, Eisbruch A, et al. CT-based definition of thoracic lymph node stations: an atlas from the University of Michigan. Int J Radiat Oncol Biol Phys 2005;63:170-178 https://doi.org/10.1016/j.ijrobp.2004.12.060
  24. Pantarotto JR, Piet AH, Vincent A, van Sörnsen de Koste JR, Senan S. Motion analysis of 100 mediastinal lymph nodes: potential pitfalls in treatment planning and adaptive strategies. Int J Radiat Oncol Biol Phys 2009;74:1092-1099 https://doi.org/10.1016/j.ijrobp.2008.09.031
  25. Liu HH, Balter P, Tutt T, Choi B, Zhang J, Wang C, et al. Assessing respiration-induced tumor motion and internal target volume using four-dimensional computed tomography for radiotherapy of lung cancer. Int J Radiat Oncol Biol Phys 2007;68:531-540 https://doi.org/10.1016/j.ijrobp.2006.12.066
  26. Li FX, Li JB, Zhang YJ, Liu TH, Tian SY, Xu M, et al. Comparison of the planning target volume based on threedimensional CT and four-dimensional CT images of non-smallcell lung cancer. Radiother Oncol 2011;99:176-180 https://doi.org/10.1016/j.radonc.2011.03.015
  27. Persson GF, Nygaard DE, Af Rosenschöld PM, Richter Vogelius I, Josipovic M, Specht L, et al. Artifacts in conventional computed tomography (CT) and free breathing fourdimensional CT induce uncertainty in gross tumor volume determination. Int J Radiat Oncol Biol Phys 2011;80:1573- 1580 https://doi.org/10.1016/j.ijrobp.2010.10.036
  28. Sarker J, Chu A, Mui K, Wolfgang JA, Hirsch AE, Chen GT, et al. Variations in tumor size and position due to irregular breathing in 4D-CT: a simulation study. Med Phys 2010;37:1254-1260 https://doi.org/10.1118/1.3298007
  29. Donnelly ED, Parikh PJ, Lu W, Zhao T, Lechleiter K, Nystrom M, et al. Assessment of intrafraction mediastinal and hilar lymph node movement and comparison to lung tumor motion using four-dimensional CT. Int J Radiat Oncol Biol Phys 2007;69:580-588 https://doi.org/10.1016/j.ijrobp.2007.05.083
  30. Weiss E, Wijesooriya K, Dill SV, Keall PJ. Tumor and normal tissue motion in the thorax during respiration: analysis of volumetric and positional variations using 4D CT. Int J Radiat Oncol Biol Phys 2007;67:296-307 https://doi.org/10.1016/j.ijrobp.2006.09.009
  31. West JB. Respiratory physiology: The essentials, 6th ed. Baltimore: Lippincott Williams & Wilkins, 2000, 113-127